Selected
Type of publications
Regions
Countries
Diseases
Publication date
Target population
311 results found
2023 ∙ Eiden, Amanda L. Barratt, Jane Nyaku, Mawuli K.
A review of factors influencing vaccination policies and programs for older adults globally
  • Acceptance
  • Adults
  • Older adults
  • Influenza
  • Pneumococcal disease
  • Herpes zoster
  • Tetanus
Rating:
Not applicable
2023 ∙ Tavabe, Nilay Rezaei Kheiri, Soleiman Dehghani, Mohsen Mohammadian-Hafshejani, Abdollah
A Systematic Review and Meta-Analysis of the Relationship between Receiving the Flu Vaccine with Acute Cerebrovascular Accident and Its Hospitalization in the Elderly
  • Efficacy/effectiveness
  • Older adults
  • Influenza
Rating:
Critically low
2023 ∙ Nichol, Bethany McCready, Jemma Louise Steen, Mary Unsworth, John Simonetti, Valentina Tomietto, Marco
Barriers and facilitators of vaccine hesitancy for COVID-19, influenza, and pertussis during pregnancy and in mothers of infants under two years: An umbrella review
  • Vaccine/vaccination
  • Acceptance
  • Pregnant women
  • Parents/caregivers
  • COVID-19
  • Influenza
  • Pertussis
Rating:
Not applicable
2023 ∙ Jones-Gray, E. Robinson, E. J. Kucharski, A. J. Fox, A. Sullivan, S. G.
Does repeated influenza vaccination attenuate effectiveness? A systematic review and meta-analysis
  • Efficacy/effectiveness
  • All age groups
  • Influenza
Rating:
Low
2023 ∙ Langer, J. Welch, V. L. Moran, M. M. Cane, A. Lopez, S. M. C. Srivastava, A. Enstone, A. L. Sears, A. Markus, K. J. Heuser, M. Kewley, R. M. Whittle, I. J.
High Clinical Burden of Influenza Disease in Adults Aged
  • Efficacy/effectiveness
  • Older adults
  • Influenza
Rating:
Critically low
2023 ∙ Barbetta, Leticia Mara Dos Santos Correia, Eduardo Thadeu de Oliveira Gismondi, Ronaldo Altenburg Odebrecht Curi Mesquita, Evandro Tinoco
Influenza Vaccination as Prevention Therapy for Stable Coronary Artery Disease and Acute Coronary Syndrome: A Meta-Analysis of Randomized Trials
  • Efficacy/effectiveness
  • Adults
  • Older adults
  • Influenza
Rating:
Critically low
2023 ∙ Brillo, E. Tosto, V. Buonomo, E.
Interventions to increase uptake of influenza vaccination in pregnancy: A systematic review and meta-analysis
  • Coverage
  • Pregnant women
  • Influenza
Rating:
Not applicable
2023 ∙ Crawford, Lori Halperin, Scott A. Dzierlenga, Michael W. Skidmore, Becky Linakis, Matthew W. Nakagawa, Shinichi Longnecker, Matthew P.
Systematic review and meta-analysis of epidemiologic data on vaccine response in relation to exposure to five principal perfluoroalkyl substances
  • Efficacy/effectiveness
  • All age groups
  • Parents/caregivers
  • Tetanus
  • Diphtheria
  • Measles
  • Rubella
  • Haemophilus influenzae type B
  • Influenza
  • Hepatitis B
  • Mumps
Rating:
Low
2023 ∙ Jordan, Karen Murchu, Eamon O. Comber, Laura Hawkshaw, Sarah Marshall, Liam O'Neill, Michelle Teljeur, Conor Harrington, Patricia Carnahan, Annasara Perez-Martin, Jaime Jesus Robertson, Anna Hayman Johansen, Kari Jonge, Jorgen de Krause, Tyra Nicolay, Nathalie Nohynek, Hanna Pavlopoulou, Ioanna Pebody, Richard Penttinen, Pasi Soler-Soneira, Marta Wichmann, Ole Ryan, Mairin
Systematic review of the efficacy, effectiveness and safety of cell-based seasonal influenza vaccines for the prevention of laboratory-confirmed influenza in individuals >=18 years of age
  • Efficacy/effectiveness
  • Safety
  • All age groups
  • Influenza
Rating:
Critically low
2023 ∙ O Murchu, Eamon Comber, Laura Jordan, Karen Hawkshaw, Sarah Marshall, Liam O'Neill, Michelle Ryan, Mairin Teljeur, Conor Carnahan, Annasara Perez, Jaime Jesus Robertson, Anna Hayman Johansen, Kari Jonge, Jorgen de Krause, Tyra Nicolay, Nathalie Nohynek, Hanna Pavlopoulou, Ioanna Pebody, Richard Penttinen, Pasi Soler-Soneira, Marta Wichmann, Ole Harrington, Patricia
Systematic review of the efficacy, effectiveness and safety of MF59 R adjuvanted seasonal influenza vaccines for the prevention of laboratory-confirmed influenza in individuals >=18 years of age
  • Safety
  • Efficacy/effectiveness
  • All age groups
  • Influenza
Rating:
Critically low